Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using Bi-Specific Antibodies and Therapeutic Vaccines Publisher



Azadi A1 ; Golchini A2 ; Delazar S4 ; Abarghooi Kahaki F5 ; Dehnavi SM6 ; Payandeh Z7 ; Eyvazi S8, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicine, De La Salle Health Sciences Institute, Dasmarinas, Philippines
  2. 2. Cancer surgery Department
  3. 3. Shiraz Medical School, Shiraz University of medical Sciences, Shiraz, Iran
  4. 4. Department of Radiology, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran
  7. 7. Immunology Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
  8. 8. Department of Biology, Tabriz Branch, Islamic Azad University, Tabriz, Iran
  9. 9. Biotechnology Research Center, Tabriz Branch, Islamic Azad University, Tabriz, Iran

Source: Biological Procedures Online Published:2021


Abstract

Colorectal cancer (CRC) is a universal heterogeneous disease that is characterized by genetic and epigenetic alterations. Immunotherapy using monoclonal antibodies (mAb) and cancer vaccines are substitute strategies for CRC treatment. When cancer immunotherapy is combined with chemotherapy, surgery, and radiotherapy, the CRC treatment would become excessively efficient. One of the compelling immunotherapy approaches to increase the efficiency of CRC therapy is the deployment of therapeutic mAbs, nanobodies, bi-specific antibodies and cancer vaccines, which improve clinical outcomes in patients. Also, among the possible therapeutic approaches for CRC patients, gene vaccines in combination with antibodies are recently introduced as a new perspective. Here, we aimed to present the current progress in CRC immunotherapy, especially using Bi-specific antibodies and dendritic cells mRNA vaccines. For this aim, all data were extracted from Google Scholar, PubMed, Scopus, and Elsevier, using keywords cancer vaccines; CRC immunotherapy and CRC mRNA vaccines. About 97 articles were selected and investigated completely based on the latest developments and novelties on bi-specific antibodies, mRNA vaccines, nanobodies, and MGD007. © 2021, The Author(s).
Related Docs
View other Related Docs
1. Immune Therapy of Melanoma: Overview of Therapeutic Vaccines, Journal of Cellular Physiology (2019)
2. Pd-1 and Cancer: Molecular Mechanisms and Polymorphisms, Immunogenetics (2018)
3. Extra Chromosomal Dna in Different Cancers: Individual Genome With Important Biological Functions, Critical Reviews in Oncology/Hematology (2021)
4. Tumor Immunology, Clinical Immunology (2022)
5. Immune Checkpoint Inhibitors and Cardiotoxicity: Possible Mechanisms, Manifestations, Diagnosis and Management, Expert Review of Anticancer Therapy (2021)
6. Pd-1/Pd-L1 Pathway: Basic Biology and Role in Cancer Immunotherapy, Journal of Cellular Physiology (2019)
7. Immune Checkpoint Inhibitor (Ici) Therapy in Central Nervous System Cancers: State-Of-The-Art and Future Outlook, International Immunopharmacology (2025)
8. A Novel Tumor Inhibitory Hybridoma Monoclonal Antibody With Dual Specificity for Her3 and Her2, Current Research in Translational Medicine (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (17)
Hamid Reza Mirzaei (1)
Other Related Docs
9. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
10. Review of the Recent Clinical Trials for Pd-1/Pd-L1 Based Lung Cancer Immunotherapy, Expert Review of Anticancer Therapy (2021)
11. Micrornas in Breast Cancer: Roles, Functions, and Mechanism of Actions, Journal of Cellular Physiology (2020)
12. Nivolumab and Pembrolizumab As Immune-Modulating Monoclonal Antibodies Targeting the Pd-1 Receptor to Treat Melanoma, Expert Review of Anticancer Therapy (2015)
13. Clinical Efficacy and Safety of Bispecific Antibodies for the Treatment of Solid Tumors: A Systematic Review and Meta-Analysis, Expert Review of Anticancer Therapy (2023)
14. The Promising Role of Monoclonal Antibodies for Gastric Cancer Treatment, Immunotherapy (2019)
15. Critical Roles of Long Noncoding Rnas in Breast Cancer, Journal of Cellular Physiology (2020)
16. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
17. Immune Checkpoints and Graves’ Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review, Journal of Ophthalmic and Vision Research (2024)
18. Immunotherapeutic Targets in Non-Small Cell Lung Cancer, Immunology (2023)
19. The Applications of Anti-Cd20 Antibodies to Treat Various B Cells Disorders, Biomedicine and Pharmacotherapy (2019)
20. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
21. Mrna Cancer Vaccines From Bench to Bedside: A New Era in Cancer Immunotherapy, Biomarker Research (2024)
22. Shedding Light on the Side Effects of Immunotherapies Used for Leukemia: An Updated Review of the Literature, Expert Review of Anticancer Therapy (2023)
23. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
24. Monoclonal Antibodies for Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
25. Exhaustion of T Lymphocytes in the Tumor Microenvironment: Significance and Effective Mechanisms, Cellular Immunology (2017)
26. Liposomal Gp100 Vaccine Combined With Cpg Odn Sensitizes Established B16f10 Melanoma Tumors to Anti Pd-1 Therapy, Iranian Journal of Basic Medical Sciences (2020)
27. The Evolving Landscape of Predictive Biomarkers in Immuno-Oncology With a Focus on Spatial Technologies, Clinical and Translational Immunology (2020)
28. Immune Checkpoint Inhibitors Therapy As the Game-Changing Approach for Pediatric Lymphoma: A Brief Landscape, Critical Reviews in Oncology/Hematology (2024)
29. Targeting Sirna in Colorectal Cancer Therapy: Nanotechnology Comes Into View, Journal of Cellular Physiology (2019)
30. Tumor Immunotherapies by Immune Checkpoint Inhibitors (Icis); the Pros and Cons, Cell Communication and Signaling (2022)
31. Recent Advances in Immune Checkpoint Therapy in Non-Small Cell Lung Cancer and Opportunities for Nanoparticle-Based Therapy, European Journal of Pharmacology (2021)
32. Monoclonal Antibody-Based Therapeutics, Targeting the Epidermal Growth Factor Receptor Family: From Herceptin to Pan Her, Journal of Pharmacy and Pharmacology (2018)
33. Immune Checkpoint Inhibitors: Review of the Existing Evidence and Challenges in Breast Cancer, Immunotherapy (2021)
34. Synthesis and Application of Magnetic@Layered Double Hydroxide As an Anti-Inflammatory Drugs Nanocarrier, Journal of Nanobiotechnology (2020)
35. Immune Checkpoint Inhibitors in Advanced Cutaneous Melanoma: A Systematic Review and Meta-Analysis of Efficacy and Review of Characteristics, Expert Review of Anticancer Therapy (2023)
36. Exosome Application in Treatment and Diagnosis of B-Cell Disorders: Leukemias, Multiple Sclerosis, and Arthritis Rheumatoid, Cellular and Molecular Biology Letters (2022)
37. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
38. Biomarkers for Immune Checkpoint Inhibitors, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
39. The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
40. Targeted Cancer Therapy Through Antibody Fragments-Decorated Nanomedicines, Journal of Controlled Release (2017)
41. Targeting the Pd-1/Pd-L1 Pathway in Glioblastoma Multiforme: Preclinical Evidence and Clinical Interventions, International Immunopharmacology (2021)
42. Structure Based Screening for Inhibitory Therapeutics of Ctla-4 Unveiled New Insights About Biology of Acth, International Journal of Peptide Research and Therapeutics (2020)
43. Improvement of Current Immunotherapies With Engineered Oncolytic Viruses That Target Cancer Stem Cells, Cell Biochemistry and Function (2024)
44. Chimeric Antigen Receptor -T Cell Therapy: Applications and Challenges in Treatment of Allergy and Asthma, Biomedicine and Pharmacotherapy (2020)
45. Antibody Based Epcam Targeted Therapy of Cancer, Review and Update, Current Cancer Drug Targets (2018)
46. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
47. The Immunogenetics of Melanoma, Advances in Experimental Medicine and Biology (2022)
48. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
49. Antimicrobial Peptides (Amps): Roles, Functions and Mechanism of Action, International Journal of Peptide Research and Therapeutics (2020)
50. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)